AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.
AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.
复制标题
DOI:
10.1016/j.cell.2011.07.032
复制
发表时间:
2011-09-02
期刊:
影响因子:
64.5
通讯作者:
Scadden DT
中科院分区:
文献类型:
--
作者:
Sykes SM;Lane SW;Bullinger L;Kalaitzidis D;Yusuf R;Saez B;Ferraro F;Mercier F;Singh H;Brumme KM;Acharya SS;Scholl C;Tothova Z;Attar EC;Fröhling S;DePinho RA;Armstrong SA;Gilliland DG;Scadden DT
AKT activation is associated with many malignancies, where AKT acts, in part, by inhibiting FOXO tumor suppressors. We show a converse role for AKT/FOXOs in acute myeloid leukemia (AML). Rather than decreased FOXO activity, we observed that FOXOs are active in ∼40% of AML patient samples regardless of genetic subtype. We also observe this activity in human MLL-AF9 leukemia allele-induced AML in mice, where either activation of Akt or compound deletion of FoxO1/3/4 reduced leukemic cell growth, with the latter markedly diminishing leukemia-initiating cell (LIC) function in vivo and improving animal survival. FOXO inhibition resulted in myeloid maturation and subsequent AML cell death. FOXO activation inversely correlated with JNK/c-JUN signaling, and leukemic cells resistant to FOXO inhibition responded to JNK inhibition. These data reveal a molecular role for AKT/FOXO and JNK/c-JUN in maintaining a differentiation blockade that can be targeted to inhibit leukemias with a range of genetic lesions.
登录
查看更多内容
影响因子:
64.5
作者:
Brunet, A;Bonni, A;Greenberg, ME
通讯作者:
Greenberg, ME
影响因子:
64.8
作者:
Naka, Kazuhito;Hoshii, Takayuki;Hirao, Atsushi
通讯作者:
Hirao, Atsushi
影响因子:
3.6
作者:
Armstrong, SA;Golub, TR;Korsmeyer, SJ
通讯作者:
Korsmeyer, SJ
影响因子:
23.9
作者:
Lee, Jae Y.;Nakada, Daisuke;Yilmaz, Omer H.;Tothova, Zuzana;Joseph, Nancy M.;Lim, Megan S.;Gilliland, D. Gary;Morrison, Sean J.
通讯作者:
Morrison, Sean J.
影响因子:
82.9
作者:
通讯作者:
--